Brickell Biotech Inc

NASDAQ:BBI   3:57:26 PM EDT
0.81
-0.02 (-2.07%)
Products, Strategic Combinations

Anges And Brickell Biotech Announce A Collaboration Agreement For The Development Of A Novel DNA Vaccine Candidate For COVID-19 In U.S.

Published: 09/08/2020 11:54 GMT
Brickell Biotech Inc (BBI) - Anges and Brickell Biotech Announce a Collaboration Agreement for the Development of a Novel Dna Vaccine Candidate for Covid-19 in the U.S.brickell Biotech Inc - Anges Will Continue to Lead Development of Its Vaccine Candidate in Japan.
Brickell Biotech Inc - Has Received Right to Develop And, If Approved, Commercialize Anges' Dna Vaccine in U.S. and Certain Underserved Countries.